Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature

التفاصيل البيبلوغرافية
العنوان:	Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature
المؤلفون:	Heregger, R., Huemer, F., Hutarew, G., Hecht, S., Cheveresan, L., Kotzot, D., Schamschula, E., Rinnerthaler, G., Melchardt, T., Weiss, L., Greil, R.
المصدر:	In ESMO Open August 2021 6(4)
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	20597029
DOI:	10.1016/j.esmoop.2021.100233